Fecal immunochemical tests from population-based colorectal cancer screening programs support prospective microbiome cohorts

Arnold M, Sierra MS, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global patterns and trends in colorectal cancer incidence and mortality. Gut. 2017;66:683–91.

Article 
PubMed 

Google Scholar 

Aarons CB, Shanmugan S, Bleier JI. Management of malignant colon polyps: current status and controversies. World J Gastroenterol. 2014;20:16178–83.

Article 
PubMed 
PubMed Central 

Google Scholar 

Schatzkin A, Freedman LS, Schiffman MH, Dawsey SM. Validation of intermediate end points in cancer research. J Natl Cancer Inst. 1990;82:1746–52.

Article 
CAS 
PubMed 

Google Scholar 

Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990;61:759–67.

Article 
CAS 
PubMed 

Google Scholar 

Peipins LA, Sandler RS. Epidemiology of colorectal adenomas. Epidemiol Rev. 1994;16:273–97.

Article 
CAS 
PubMed 

Google Scholar 

Garrett WS. The gut microbiota and colon cancer. Science. 2019;364:1133–5.

Article 
CAS 
PubMed 

Google Scholar 

Tilg H, Adolph TE, Gerner RR, Moschen AR. The intestinal microbiota in colorectal cancer. Cancer Cell. 2018;33:954–64.

Article 
CAS 
PubMed 

Google Scholar 

Zou S, Fang L, Lee MH. Dysbiosis of gut microbiota in promoting the development of colorectal cancer. Gastroenterol Rep. 2018;6:1–12.

Article 

Google Scholar 

Castellarin M, Warren RL, Freeman JD, Dreolini L, Krzywinski M, Strauss J, et al. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res. 2012;22:299–306.

Article 
CAS 
PubMed 

Google Scholar 

Kostic AD, Chun E, Meyerson M, Garrett WS. Microbes and inflammation in colorectal cancer. Cancer Immunol Res. 2013;1:150–7.

Article 
CAS 
PubMed 

Google Scholar 

Mima K, Nishihara R, Qian ZR, Cao Y, Sukawa Y, Nowak JA, et al. Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis. Gut. 2016;65:1973–80.

Article 
CAS 
PubMed 

Google Scholar 

Mira-Pascual L, Cabrera-Rubio R, Ocon S, Costales P, Parra A, Suarez A, et al. Microbial mucosal colonic shifts associated with the development of colorectal cancer reveal the presence of different bacterial and archaeal biomarkers. J Gastroenterol. 2015;50:167–79.

Article 
CAS 
PubMed 

Google Scholar 

Zouiouich S, Wan Y, Vogtmann E, Porras C, Abnet CC, Shi J, et al. Sample size estimations based on human microbiome temporal stability over 6 months: a shallow shotgun metagenome sequencing analysis. Cancer Epidemiol Biomark Prev. 2025;34:588–97.

Article 
CAS 

Google Scholar 

Byrd DA, Chen J, Vogtmann E, Hullings A, Song SJ, Amir A, et al. Reproducibility, stability, and accuracy of microbial profiles by fecal sample collection method in three distinct populations. PLoS ONE. 2019;14:e0224757.

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Byrd DA, Sinha R, Hoffman KL, Chen J, Hua X, Shi J, et al. Comparison of methods to collect fecal samples for microbiome studies using whole-genome shotgun metagenomic sequencing. mSphere. 2020;5:1.

Article 

Google Scholar 

Gudra D, Shoaie S, Fridmanis D, Klovins J, Wefer H, Silamikelis I, et al. A widely used sampling device in colorectal cancer screening programmes allows for large-scale microbiome studies. Gut. 2019;68:1723–5.

Article 
CAS 
PubMed 

Google Scholar 

Rounge TB, Meisal R, Nordby JI, Ambur OH, de Lange T, Hoff G. Evaluating gut microbiota profiles from archived fecal samples. BMC Gastroenterol. 2018;18:171.

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Sinha R, Chen J, Amir A, Vogtmann E, Shi J, Inman KS, et al. Collecting fecal samples for microbiome analyses in epidemiology studies. Cancer Epidemiol Biomark Prev. 2016;25:407–16.

Article 

Google Scholar 

Vogtmann E, Chen J, Amir A, Shi J, Abnet CC, Nelson H, et al. Comparison of collection methods for fecal samples in microbiome studies. Am J Epidemiol. 2017;185:115–23.

Article 
PubMed 

Google Scholar 

Vogtmann E, Chen J, Kibriya MG, Chen Y, Islam T, Eunes M, et al. Comparison of fecal collection methods for microbiota studies in Bangladesh. Appl Environ Microbiol. 2017;83:e00361-17.

Zouiouich S, Mariadassou M, Rue O, Vogtmann E, Huybrechts I, Severi G, et al. Comparison of fecal sample collection methods for microbial analysis embedded within colorectal cancer screening programs. Cancer Epidemiol Biomark Prev. 2022;31:305–14.

Article 
CAS 

Google Scholar 

Riboli E, Hunt KJ, Slimani N, Ferrari P, Norat T, Fahey M, et al. European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr. 2002;5:1113–24.

Article 
CAS 
PubMed 

Google Scholar 

Truong DT, Franzosa EA, Tickle TL, Scholz M, Weingart G, Pasolli E, et al. MetaPhlAn2 for enhanced metagenomic taxonomic profiling. Nat Methods. 2015;12:902–3.

Article 
CAS 
PubMed 

Google Scholar 

Truong DT, Tett A, Pasolli E, Huttenhower C, Segata N. Microbial strain-level population structure and genetic diversity from metagenomes. Genome Res. 2017;27:626–38.

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Beghini F, McIver LJ, Blanco-Miguez A, Dubois L, Asnicar F, Maharjan S, et al. Integrating taxonomic, functional, and strain-level profiling of diverse microbial communities with bioBakery 3. eLife. 2021;10:e65088.

McMurdie PJ, Holmes S. phyloseq: an R package for reproducible interactive analysis and graphics of microbiome census data. PLoS ONE. 2013;8:e61217.

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Oksanen J, Blanchet FG, Friendly M, Kindt R, Legendre P, McGlinn D, et al. vegan: community ecology package. R Package Version. 2015;2:2019.

Google Scholar 

Wirbel J, Pyl PT, Kartal E, Zych K, Kashani A, Milanese A, et al. Meta-analysis of fecal metagenomes reveals global microbial signatures that are specific for colorectal cancer. Nat Med. 2019;25:679–89.

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Thomas AM, Manghi P, Asnicar F, Pasolli E, Armanini F, Zolfo M, et al. Metagenomic analysis of colorectal cancer datasets identifies cross-cohort microbial diagnostic signatures and a link with choline degradation. Nat Med. 2019;25:667–78.

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Zhao N, Chen J, Carroll IM, Ringel-Kulka T, Epstein MP, Zhou H, et al. Testing in microbiome-profiling studies with MiRKAT, the microbiome regression-based kernel association test. Am J Hum Genet. 2015;96:797–807.

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Aguado Loi CX, Martinez Tyson D, Chavarria EA, Gutierrez L, Klasko L, Davis S, et al. Simple and easy:’ providers’ and latinos’ perceptions of the fecal immunochemical test (FIT) for colorectal cancer screening. Ethn Health. 2020;25:206–21.

Article 
PubMed 

Google Scholar 

Gwede CK, Sutton SK, Chavarria EA, Gutierrez L, Abdulla R, Christy SM, et al. A culturally and linguistically salient pilot intervention to promote colorectal cancer screening among Latinos receiving care in a Federally Qualified Health Center. Health Educ Res. 2019;34:310–20.

Article 
PubMed 
PubMed Central 

Google Scholar 

Davis SN, Govindaraju S, Jackson B, Williams KR, Christy SM, Vadaparampil ST, et al. Recruitment techniques and strategies in a community-based colorectal cancer screening study of men and women of african ancestry. Nurs Res. 2018;67:212–21.

Article 
PubMed 
PubMed Central 

Google Scholar 

Davis SN, Christy SM, Chavarria EA, Abdulla R, Sutton SK, Schmidt AR, et al. A randomized controlled trial of a multicomponent, targeted, low-literacy educational intervention compared with a nontargeted intervention to boost colorectal cancer screening with fecal immunochemical testing in community clinics. Cancer. 2017;123:1390–400.

Article 
PubMed 

Google Scholar 

Baxter NT, Koumpouras CC, Rogers MA, MTt Ruffin, Schloss PD. DNA from fecal immunochemical test can replace stool for detection of colonic lesions using a microbiota-based model. Microbiome. 2016;4:59.

Article 
PubMed 
PubMed Central 

Google Scholar 

Hale VL, Chen J, Johnson S, Harrington SC, Yab TC, Smyrk TC, et al. Shifts in the fecal microbiota associated with adenomatous polyps. Cancer Epidemiol Biomark Prev. 2017;26:85–94.

Article 
CAS 

Google Scholar 

Zhang Y, Yu X, Yu E, Wang N, Cai Q, Shuai Q, et al. Changes in gut microbiota and plasma inflammatory factors across the stages of colorectal tumorigenesis: a case-control study. BMC Microbiol. 2018;18:92.

Article 
PubMed 
PubMed Central 

Google Scholar 

Bateman LA, Ku WM, Heslin MJ, Contreras CM, Skibola CF, Nomura DK. Argininosuccinate Synthase 1 is a Metabolic Regulator of Colorectal Cancer Pathogenicity. ACS Chem Biol. 2017;12:905–11.

Article 
CAS 
PubMed 

Google Scholar 

Young C, Wood HM, Fuentes Balaguer A, Bottomley D, Gallop N, Wilkinson L, et al. Microbiome analysis of more than 2000 NHS bowel cancer screening programme samples shows the potential to improve screening accuracy. Clin Cancer Res. 2021;27:2246–54.

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Young C, Wood HM, Seshadri RA, Van Nang P, Vaccaro C, Melendez LC, et al. The colorectal cancer-associated faecal microbiome of developing countries resembles that of developed countries. Genome Med. 2021;13:27.

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Grobbee EJ, Lam SY, Fuhler GM, Blakaj B, Konstantinov SR, Bruno MJ, et al. First steps towards combining faecal immunochemical testing with the gut microbiome in colorectal cancer screening. U Eur Gastroenterol J. 2020;8:293–302.

Article 
CAS 

Google Scholar